IRCT20181120041710N1
Completed
Phase 2
Effects of isoflavones on cardiovascular disease risk factors and bone metabolism markers in peritoneal dialysis patients
ational Nutrition and Food Technology Research Institute0 sites44 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Nutrition and Food Technology Research Institute
- Enrollment
- 44
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Continuous Ambulatory Peritoneal Dialysis for 6 months or more
- •Body mass index (BMI) below 35
Exclusion Criteria
- •Infectious diseases (especially peritonitis) and inflammatory diseases
- •Liver diseases
- •Past medical history of cancer
- •Receiving glucocorticoid drugs, non\-steroidal anti\-inflammatory drugs
- •Receiving isoflavone supplements
- •Constant consumption of soy or foods containing soy in the diet
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis PatientsPeritoneal Dialysis PatientsNCT03773029National Nutrition and Food Technology Institute47
Recruiting
Phase 2
Effects of isoflavones in peritoneal dialysis patientsEnd stage of renal disease.Chronic kidney disease, stage 5N18.5IRCT20091116002716N4ational Nutrition and Food Technology Research Institute44
Completed
Phase 3
The effects of isoflavone supplementation in the treatment of non atypical endometrial hyperplasiaIRCT20200531047614N3Kashan University of Medical Sciences100
Completed
Not Applicable
The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and LipidsType 2 Diabetes MellitusNCT00951912Sun Yat-sen University165
Unknown
Not Applicable
Beneficial effects of soy isoflavones and non-soy isoflavones in Bangladeshi postmenopausal womeCTRI/2017/08/009363Bangladesh University of Health Sciences BUHS